Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-2.23%
Shrank
—
—
Grew
—
1 Year
Score—
Net Growth-2.23%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
1.9
-70.79%
20%
—
-82.65%
20%
—
5 Years
Score1.9
Net Growth-70.79%
Net Trend20%
Net Income Consistency—
Rev Growth-82.65%
Rev Trend20%
Revenue Consistency—
Immuneering Corp fundamental performance
Between 2021 and 2025, revenue declined from $ 2M to $ 0.00 and net income went from -$ 33M to -$ 56M. Revenue increased in 20% of the years measured; net income in 20%.
Immuneering Corp currently holds a 5-year HDB Score of 1.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 5.07 | — |
1 Year2025-08-12 | $ 3.25 | 56.00% |
5 Years2021-08-12 | $ 28.18 | -82.01% |
All Time2021-07-30 | $ 17.59 | -71.18% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-30 |
|---|---|---|---|---|
| Price | $ 5.07 | $ 3.25 | $ 28.18 | $ 17.59 |
| Return | — | 56.00% | -82.01% | -71.18% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 360.96K | -$ 57M | $ 149M |
| 2025 | $ 0.00 | -$ 56M | $ 172M |
| 2024 | $ 0.00 | -$ 61M | $ 36M |
| 2023 | $ 455.00 | -$ 53M | $ 85M |
| 2022 | $ 316.95K | -$ 50M | $ 105M |
| IPO2021 | $ 2M | -$ 33M | $ 149M |
Explore beyond IMRX
You're looking at Immuneering Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
